Vaxcyte initiates public offering of stock, warrants, and convertible notes, leading to a 2.4% decline in shares.

Observed price moves

• PCVX-8.06%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.